Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding? | Biochem Soc Trans | 2022 | 35226061 | PubTator, text mining | PubMed |
| Spondylometaepiphyseal Dysplasia Short Limb-Abnormal Calcification Type in Turkish Patients Reveals a Novel Mutation and New Features. | Mol Syndromol | 2022 | 35221872 | PubTator, text mining | PubMed |
| Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies. | Cancers (Basel) | 2022 | 35205799 | PubTator, text mining | PubMed |
| Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors. | Cancers (Basel) | 2022 | 35205794 | PubTator, text mining | PubMed |
| Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas. | Cancers (Basel) | 2022 | 35205778 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact. | Cancers (Basel) | 2022 | 35205677 | PubTator, text mining | PubMed |
| Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update. | Biomedicines | 2022 | 35203580 | PubTator, text mining | PubMed |
| Composite Clonal Analysis Reveals Transition of NSCLC Subtypes Through Accumulation of Gene Mutations: A Case Report. | JTO Clin Res Rep | 2022 | 35199052 | PubTator, text mining | PubMed |
| Functional Interactions Between lncRNAs/circRNAs and miRNAs: Insights Into Rheumatoid Arthritis. | Front Immunol | 2022 | 35197980 | PubTator, text mining | PubMed |
| Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases. | Front Mol Biosci | 2022 | 35187086 | PubTator, text mining | PubMed |
| Osteomodulin attenuates smooth muscle cell osteogenic transition in vascular calcification. | Clin Transl Med | 2022 | 35184400 | PubTator, text mining | PubMed |
| Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe. | Cancers (Basel) | 2022 | 35159047 | PubTator, text mining | PubMed |
| The collagen receptor, discoidin domain receptor 2, functions in Gli1-positive skeletal progenitors and chondrocytes to control bone development. | Bone Res | 2022 | 35140200 | PubTator, text mining | PubMed |
| A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. | Nat Cancer | 2022 | 35121989 | PubTator, text mining | PubMed |
| Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma. | Cell Death Discov | 2022 | 35091546 | PubTator, text mining | PubMed |
| Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer. | Sci Rep | 2022 | 35087134 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 2: A New Target in Cancer. | Oncol Res Treat | 2022 | 35073544 | PubTator, text mining | PubMed |
| Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma. | J Biomed Sci | 2022 | 35062934 | PubTator, text mining | PubMed |
| Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment. | Int J Mol Sci | 2022 | 35055190 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Influence the Biological Properties of Malignant Tumours via Paracrine Secretion and Exosome Production. | Int J Mol Sci | 2022 | 35055153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=35